Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Predictors of Catching Covid-19 Infection During Pandemic Stage in Patients With Multiple Sclerosis (Ms) Publisher



Ghajarzadeh M1, 2 ; Mirmosayyeb O3 ; Molazadeh NM1 ; Sahraian MA1 ; Bonavita S4 ; Shaygannejad V5
Authors
Show Affiliations
Authors Affiliations
  1. 1. Multiple Sclerosis Research Center, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran
  2. 2. Universal Council of Epidemiology (UCE), Universal Scientific Education and Research Network (USERN), Tehran University of Medical Sciences, Tehran, Iran
  3. 3. Isfahan Neurosciences Research Center, Isfahan University of Medical Sciences, Isfahan, Iran
  4. 4. Department of Advanced Medical and Surgical Sciences, University of Campania Luigi Vanvitelli, Naples, Italy
  5. 5. Department of Neurology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran

Source: International Journal of Preventive Medicine Published:2022


Abstract

Background: Patients with multiple sclerosis (MS) are considered at higher risk of COVID-19 infection due to treatment with immune modulators and immune-suppressive agents. The exact risk factors are not clear. So, we aimed to conduct a study to determine the predictors of catching COVID-19 infection during the pandemic stage in patients with multiple sclerosis (MS). Methods: We conducted a multicenter screening study and developed an online questionnaire to collect patients' self-reported demographic features along with MS-related and COVID-19-related information. The online questionnaire link was released by the Iran Multiple Sclerosis Society (IMSS) social media channel, accessible for 4160 MS patients totally and also was sent by WhatsApp for nonmember cases. Results: Totally, 1448 MS patients participated in our study. Twenty-five (1.7%) patients were diagnosed with COVID-19, from which 4 were hospitalized, 4 were treated with medical therapy, and 17 patients had home-quarantine. The patients with COVID-19 diagnosis were more frequently treated with rituximab (28% vs 24%, P = 0.001) than others, and cardiovascular comorbidity was more frequent in this group (8% vs 1.6%, P = 0.01). Regression analysis showed that cardiovascular disease was a significant positive predictor of COVID-19 infection (OR = 5.2, 95% CI: 1.1-23.7). Conclusions: Patients with MS who have cardiovascular disease should be more monitored for COVID-19 infection as they are at higher risk of infection. © 2022 Acoustical Society of America. All rights reserved.
Related Docs
View other Related Docs
1. The Prevalence of Covid-19 Infection in Patients With Multiple Sclerosis (Ms): A Systematic Review and Meta-Analysis, Neurological Sciences (2021)
2. Characteristics of Covid-19 in Patients With Multiple Sclerosis, Multiple Sclerosis and Related Disorders (2022)
3. Evaluation of the Rate of Covid-19 Infection, Hospitalization and Death Among Iranian Patients With Multiple Sclerosis, Multiple Sclerosis and Related Disorders (2020)
4. Covid-19 and Disease-Modifying Therapies in Patients With Demyelinating Diseases of the Central Nervous System: A Systematic Review, Multiple Sclerosis and Related Disorders (2021)
5. The Immunological Therapeutic Strategies for Controlling Multiple Sclerosis: Considerations During the Covid-19 Pandemic, Biomolecules (2021)
6. The Study of Covid-19 Infection Following Vaccination in Patients With Multiple Sclerosis, Multiple Sclerosis and Related Disorders (2022)
7. The Outcome of Covid-19 in Patients With a History of Taking Rituximab: A Narrative Review, Iranian Journal of Medical Sciences (2021)
8. Favorable Outcome After Covid-19 Infection in a Multiple Sclerosis Patient Initiated on Ocrelizumab During the Pandemic, Multiple Sclerosis and Related Disorders (2020)
Experts (# of related papers)
View all Related Experts
Mohammad Ali Sahraian (11)
Abdolreaza Naser Moghadasi (10)
Other Related Docs
9. Characteristics of Covid-19 Disease in Multiple Sclerosis Patients, Multiple Sclerosis and Related Disorders (2020)
10. Multiple Sclerosis and Covid-19: A Retrospective Study in Iran, PLoS ONE (2023)
11. Pivotal Exigencies of Dental Services and Related Professions, in Covid- 19 Pandemic: A Systematic Literature Review, Tehran University Medical Journal (2021)
12. Are Patients With Multiple Sclerosis (Ms) at Higher Risk of Covid-19 Infection?, Neurological Sciences (2020)
13. Assessment of Covid-19 Vaccine Attitude in People With Multiple Sclerosis, Its Correlation With Demographic Factors, and Fear of Coronavirus: A Cross-Sectional Survey, Current Journal of Neurology (2022)
14. Can Pulse Steroid Therapy Increase the Risk of Infection by Covid-19 in Patients With Multiple Sclerosis?, Clinical Neurology and Neurosurgery (2021)
15. Covid-19 Among Patients With Multiple Sclerosis a Systematic Review, Neurology: Neuroimmunology and NeuroInflammation (2021)
16. Association Between Disease-Modifying Therapies and Adverse Clinical Outcomes in Multiple Sclerosis Patients With Covid-19 Infection, Multiple Sclerosis and Related Disorders (2022)
17. Molecular Evaluation of the Novel Coronavirus Infection of Cockroaches and Flies Collected From Kamkar-Arabnia Hospital in Qom City, Central Iran: With Innovated Internal Control, Journal of Arthropod-Borne Diseases (2022)
18. A Narrative Literature Review on Traditional Medicine Options for Treatment of Corona Virus Disease 2019 (Covid-19), Complementary Therapies in Clinical Practice (2020)
19. Fear of Re-Infection, Relapse, and Anxiety During Covid-19 Pandemic in Patients With Multiple Sclerosis: A Multi-Center Study, Current Journal of Neurology (2023)
20. The Effects of the Covid-19 Pandemic on the Elderly: A Systematic Review, Iranian Journal of Ageing (2021)
21. Geriatrics and Covid-19, Advances in Experimental Medicine and Biology (2021)
22. The Evaluation of Clinical Symptoms and Underlying Factors in Infected Patients With Covid-19, Tehran University Medical Journal (2021)
23. Importance of T-Cell Response to Covid-19 Vaccination in Patients With Multiple Sclerosis Treated by Anti-Cd20 Therapies: New Vaccines Are Required to Be Developed, Multiple Sclerosis and Related Disorders (2021)
24. Neurologic Involvement in Covid-19: Radiologists’ Perspective, Academic Radiology (2020)
25. The Effect of Vitamin D Supplements on Clinical and Para-Clinical Outcomes in Patients With Multiple Sclerosis: Protocol for a Systematic Review, JMIR Research Protocols (2019)
26. Case Fatality Rate of Covid-19: A Systematic Review and Meta-Analysis, Journal of Preventive Medicine and Hygiene (2021)
27. Nanostructures for Prevention, Diagnosis, and Treatment of Viral Respiratory Infections: From Influenza Virus to Sars-Cov-2 Variants, Journal of Nanobiotechnology (2023)
28. Covid-19 Infection and Liver Injury: Clinical Features, Biomarkers, Potential Mechanisms, Treatment, and Management Challenges, World Journal of Clinical Cases (2021)
29. Coronavirus Disease 2019 (Covid-19) in Pediatric Patients With Autoimmune Disorders, European Journal of Pediatrics (2023)
30. Association of Vitamin D Receptor Gene Polymorphisms and Clinical/Severe Outcomes of Covid-19 Patients, Infection# Genetics and Evolution (2021)
31. Geriatric Challenges in the New Coronavirus Disease-19 (Covid-19) Pandemic: A Systematic Review, Medical Journal of the Islamic Republic of Iran (2020)
32. Immune-Epidemiological Parameters of the Novel Coronavirus–A Perspective, Expert Review of Clinical Immunology (2020)
33. Antiviral Optical Techniques As a Possible Novel Approach to Covid-19 Treatment, Journal of Innovative Optical Health Sciences (2021)
34. The Emerging Role of Probiotics As a Mitigation Strategy Against Coronavirus Disease 2019 (Covid-19), Archives of Virology (2021)
35. The Predictive Power of Serum Vitamin D for Poor Outcomes in Covid-19 Patients, Food Science and Nutrition (2021)
36. The Possible Direct Correlation Between Cognitive Impairment and Fear of Catching Covid-19 Among Patients With Multiple Sclerosis, Iranian Journal of Psychiatry (2021)
37. Adverse Events Reported by Iranian Patients With Multiple Sclerosis After the First Dose of Sinopharm Bbibp-Corv, Vaccine (2021)
38. Covid-19 Related Knowledge, Anxiety, Depression and Physical Activity Among Iranian People With Relapsing-Remitting Multiple Sclerosis During Covid-19 Pandemic: An Online Cross-Sectional Survey, European Journal of Physiotherapy (2023)
39. Covid-19 Infection in Kidney Transplant Recipients From a Single Center in Iran, Experimental and Clinical Transplantation (2022)
40. Sars-Cov-2: Current Trends in Emerging Variants, Pathogenesis, Immune Responses, Potential Therapeutic, and Vaccine Development Strategies, International Immunopharmacology (2021)
41. The Prevalence of Electrolyte Imbalances and Their Relationship With Disease Severity in Hospitalized Covid-19 Patients, Archives of Clinical Infectious Diseases (2022)
42. Covid-19: Significance of Antibodies, Human Antibodies (2020)
43. Epidemiological and Clinical Characteristics of Covid-19 Patients Studied by Jiroft University of Medical Sciences: Southeast of Iran, Journal of Advances in Medical and Biomedical Research (2021)
44. Prevalence of Multiple Sclerosis (Ms) in Iran: A Systematic Review and Meta-Analysis, Neurological Sciences (2022)
45. Gut Microbiota, Angiotensin-Converting Enzyme, Celiac Disease, and Risk of Covid-19 Infection: A Review, Gastroenterology and Hepatology from Bed to Bench (2021)
46. Covid-19 Infection and Vitamin D: Current Scenario and Future Prospects, Current Drug Discovery Technologies (2021)
47. Altered Immunoemotional Regulatory System in Covid-19: From the Origins to Opportunities, Journal of Neuroimmunology (2021)
48. Coronavirus Disease 2019 (Covid-19): Immune Responses, Transmission, and Clinical Features: An Update, Journal of Cellular and Molecular Anesthesia (2020)
49. Ethical Considerations in Neurology During the Covid-19 Pandemic, Neurological Sciences (2021)
50. Dental Care Management During the Covid-19 Outbreak, Special Care in Dentistry (2020)